Subscribe
patent_istock-643607264_warchi-
warchi / iStockphoto.com
11 October 2018Americas

Eli Lilly takes Adocia to court over insulin patents

Eli Lilly has filed a complaint (pdf) against France-based biotechnology company Adocia over patents relating to fast-acting insulin.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Americas
Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Americas
Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.

More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Americas
Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug